A new publication involving thymosin beta-4 was released on October 26, 2026. The study, titled "Paracrine TMSB4X signaling from oligodendrocytes promotes diffuse glioma dissemination," appeared in the journal Oncogene. Thymosin beta-4 remains classified as an unapproved research compound. The publication is listed under PubMed ID 42934271 and is accessible through PubMed's database. This entry represents a new addition to the scientific literature referencing TMSB4X, the gene encoding thymosin beta-4. No findings, conclusions, or data from the study are detailed beyond its title and publication venue. Readers interested in the broader context of thymosin beta-4 research can consult the compound overview for additional background information on its research status and history.
New Publication: Thymosin Beta-4 Signaling Study in Oncogene
See the full thymosin beta-4 overview
Source: https://pubmed.ncbi.nlm.nih.gov/42934271/